Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism,
represents a major cause of morbidity and mortality in patients with cancer. Arterial …
represents a major cause of morbidity and mortality in patients with cancer. Arterial …
Red blood cells in thrombosis
JR Byrnes, AS Wolberg - Blood, The Journal of the American …, 2017 - ashpublications.org
Red blood cells (RBCs) have historically been considered passive bystanders in
thrombosis. However, clinical and epidemiological studies have associated quantitative and …
thrombosis. However, clinical and epidemiological studies have associated quantitative and …
Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major …
MF Leahy, A Hofmann, S Towler, KM Trentino… - …, 2017 - Wiley Online Library
BACKGROUND Patient blood management (PBM) programs are associated with improved
patient outcomes, reduced transfusions and costs. In 2008, the Western Australia …
patient outcomes, reduced transfusions and costs. In 2008, the Western Australia …
Mitigating acute chemotherapy-associated adverse events in patients with cancer
NM Kuderer, A Desai, MB Lustberg… - Nature Reviews Clinical …, 2022 - nature.com
Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …
Venous thrombosis
Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States
AA Khorana, M Dalal, J Lin, GC Connolly - Cancer, 2013 - Wiley Online Library
BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …
Cancer and venous thromboembolic disease: a review
E Donnellan, AA Khorana - The Oncologist, 2017 - academic.oup.com
Venous thromboembolism (VTE), including deep‐vein thrombosis and pulmonary embolism,
represents a major cause of morbidity and mortality in cancer patients. Patients with cancer …
represents a major cause of morbidity and mortality in cancer patients. Patients with cancer …
Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - frontiersin.org
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations
G Van Assche, A Dignass, B Bokemeyer… - Journal of Crohn's …, 2013 - academic.oup.com
Second European evidence-based consensus on the diagnosis and management of ulcerative
colitis Part 3: Special situations | Journal of Crohn's and Colitis | Oxford Academic Skip to …
colitis Part 3: Special situations | Journal of Crohn's and Colitis | Oxford Academic Skip to …